Lu, L., Barbi, J. & Pan, F. The regulation of immune tolerance by FOXP3. Nat. Rev. Immunol. 17, 703–717 (2017).
Article CAS PubMed PubMed Central Google Scholar
Panduro, M., Benoist, C. & Mathis, D. Tissue Tregs. Annu. Rev. Immunol. 34, 609–633 (2016).
Article CAS PubMed PubMed Central Google Scholar
Miyara, M. et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899–911 (2009).
Article CAS PubMed Google Scholar
Duhen, T., Duhen, R., Lanzavecchia, A., Sallusto, F. & Campbell, D. J. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector TH cells. Blood 119, 4430–4440 (2012).
Article CAS PubMed PubMed Central Google Scholar
Halim, L. et al. An atlas of human regulatory T helper-like cells reveals features of TH2-like Tregs that support a tumorigenic environment. Cell Rep. 20, 757–770 (2017).
Article CAS PubMed PubMed Central Google Scholar
Cheru, N., Hafler, D. A. & Sumida, T. S. Regulatory T cells in peripheral tissue tolerance and diseases. Front. Immunol. 14, 1154575 (2023).
Article CAS PubMed PubMed Central Google Scholar
Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523–532 (2008).
Article CAS PubMed PubMed Central Google Scholar
Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. & Yamaguchi, T. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105–1111 (2009).
Article CAS PubMed Google Scholar
Schmidt, A., Oberle, N. & Krammer, P. H. Molecular mechanisms of Treg-mediated T cell suppression. Front. Immunol. 3, 51 (2012).
Article CAS PubMed PubMed Central Google Scholar
Trujillo-Ochoa, J. L., Kazemian, M. & Afzali, B. The role of transcription factors in shaping regulatory T cell identity. Nat. Rev. Immunol. 23, 842–856 (2023).
Article CAS PubMed Google Scholar
Carbone, F. et al. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 20, 69–74 (2014).
Article CAS PubMed Google Scholar
John, K. et al. Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis. Cell Death Dis. 8, 3219 (2017).
Article PubMed PubMed Central Google Scholar
Brunkow, M. E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73 (2001).
Article CAS PubMed Google Scholar
Wildin, R. S. et al. X-Linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18–20 (2001).
Article CAS PubMed Google Scholar
Viglietta, V., Baecher-Allan, C., Weiner, H. L. & Hafler, D. A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971–979 (2004).
Article CAS PubMed PubMed Central Google Scholar
Dominguez-Villar, M., Baecher-Allan, C. M. & Hafler, D. A. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673–675 (2011).
Article CAS PubMed PubMed Central Google Scholar
Baecher-Allan, C. M. et al. CD2 costimulation reveals defective activity by human CD4+CD25hi regulatory cells in patients with multiple sclerosis. J. Immunol. 186, 3317–3326 (2011).
Article CAS PubMed Google Scholar
Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., Schatz, D. A. & Atkinson, M. A. Functional defects and the influence of age on the frequency of CD4+CD25+ T-cells in type 1 diabetes. Diabetes 54, 1407–1414 (2005).
Article CAS PubMed Google Scholar
Lindley, S. et al. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 54, 92–99 (2005).
Article CAS PubMed Google Scholar
Haseda, F., Imagawa, A., Murase-Mishiba, Y., Terasaki, J. & Hanafusa, T. CD4+CD45RA–FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes. Clin. Exp. Immunol. 173, 207–216 (2013).
Article CAS PubMed PubMed Central Google Scholar
van Roon, J. A., Hartgring, S. A., van der Wurff-Jacobs, K. M., Bijlsma, J. W. & Lafeber, F. P. Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients. Rheumatology 49, 2084–2089 (2010).
Nie, H. et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat. Med. 19, 322–328 (2013).
Article CAS PubMed Google Scholar
Bonelli, M. et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 20, 861–868 (2008).
Article CAS PubMed Google Scholar
Hsieh, C. S., Lee, H. M. & Lio, C. W. Selection of regulatory T cells in the thymus. Nat. Rev. Immunol. 12, 157–167 (2012).
Article CAS PubMed Google Scholar
Lathrop, S. K. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250–254 (2011).
Article ADS CAS PubMed PubMed Central Google Scholar
Chen, W. et al. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886 (2003).
Article CAS PubMed PubMed Central Google Scholar
Kanamori, M., Nakatsukasa, H., Okada, M., Lu, Q. & Yoshimura, A. Induced regulatory T cells: their development, stability, and applications. Trends Immunol. 37, 803–811 (2016).
Article CAS PubMed Google Scholar
Hill, J. A. et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27, 786–800 (2007).
Article CAS PubMed Google Scholar
Allan, S. E. et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19, 345–354 (2007).
Article CAS PubMed Google Scholar
Tran, D. Q., Ramsey, H. & Shevach, E. M. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 110, 2983–2990 (2007).
Article CAS PubMed PubMed Central Google Scholar
Thornton, A. M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433–3441 (2010).
Article CAS PubMed Google Scholar
Weiss, J. M. et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ Treg cells. J. Exp. Med. 209, 1723–1742, S1 (2012).
Article CAS PubMed PubMed Central Google Scholar
Szurek, E. et al. Differences in expression level of helios and neuropilin-1 do not distinguish thymus-derived from extrathymically-induced CD4+Foxp3+ regulatory T cells. PLoS ONE 10, e0141161 (2015).
Article PubMed PubMed Central Google Scholar
Elkord, E. Helios should not be cited as a marker of human thymus-derived Tregs. Commentary: Helios+ and Helios– cells coexist within the natural FOXP3+ T regulatory cell subset in humans. Front. Immunol. 7, 276 (2016).
Article PubMed PubMed Central Google Scholar
Haribhai, D. et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35, 109–122 (2011).
留言 (0)